| GTO ID | GTC3551 |
| Trial ID | NCT05990751 |
| Disease | Neuroblastoma |
| Altered gene | GD2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GD2 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma |
| Year | 2024 |
| Country | United Kingdom |
| Company sponsor | University College, London |
| Other ID(s) | UCL\142424 |
| Cohort 1 | |||||||||||
|
|||||||||||